Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | EVP, Chief Commercial Officer | January 10, 2025 | January 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 10, 2025 · Filed January 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,992 |
Reported balance
After 2025-01-10 transaction · row 1
1 source rowRow 1 · 2025-01-10 · Tax withholding · Disposed 5,689 · Balance 100,992 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2025 Filed Jan 15, 2025 00:14 UTC | CorMedix Inc. CRMD · Entity 5280 | Tax withholdingCommon Stock | 5,689 | $11.19 | $63,659.91 |
DisclosureSEC source: 0001213900-25-003533 · ownership.xml · nonDerivative · entry 1 Mistry Erin · CIK 0001962774 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,992 Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 02:40 UTC | CorMedix Inc. CRMD · Entity 5280 | Tax withholdingCommon Stock | 7,830 | $8.22 | $64,362.60 |
DisclosureSEC source: 0001213900-25-001358 · ownership.xml · nonDerivative · entry 2 Mistry Erin · CIK 0001962774 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,681 Read SEC document |
| January 02, 2025 Filed Jan 7, 2025 02:40 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-001358 · ownership.xml · nonDerivative · entry 1 Mistry Erin · CIK 0001962774 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,511 F1 · price: These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| October 31, 2024 Filed Dec 13, 2024 21:15 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 1,500 | $9.99 | $14,984.85 |
DisclosureSEC source: 0000899140-24-001352 · form4.xml · nonDerivative · entry 1 Mistry Erin · CIK 0001962774 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,011 Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:09 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 100,000 | $0.00 Strike: $3.47 | $0.00 |
DisclosureSEC source: 0000929638-24-000132 · form4.xml · derivative · entry 3 Mistry Erin · CIK 0001962774 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-01-11 F2 · derivative.exercise_date: These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:09 UTC | CorMedix Inc. CRMD · Entity 5280 | Tax withholdingCommon Stock | 4,389 | $3.47 | $15,229.83 |
DisclosureSEC source: 0000929638-24-000132 · form4.xml · nonDerivative · entry 2 Mistry Erin · CIK 0001962774 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,511 Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:09 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-24-000132 · form4.xml · nonDerivative · entry 1 Mistry Erin · CIK 0001962774 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,900 F1 · price: These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:00 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 1,000 | $4.00 | $4,000.00 |
DisclosureSEC source: 0000929638-23-003205 · form4.xml · nonDerivative · entry 1 Mistry Erin · CIK 0001962774 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,900 Read SEC document |
| January 14, 2023 Filed Jan 20, 2023 23:05 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 75,000 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001567619-23-001095 · doc1.xml · derivative · entry 2 Mistry Erin · CIK 0001962774 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-01-14 F1 · derivative.exercise_date: These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.